This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Astrazeneca Pharmaceuticals LP. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dewald Van Dyk and His Patent Work
Introduction
Dewald Van Dyk is an inventor associated with Wilmington, Delaware, and AstraZeneca Pharmaceuticals LP. His patent work includes research into chimeric antigen receptors targeting STEAP2.
Latest Patents
Van Dyk is named on the patent “Anti-STEAP2 Chimeric Antigen Receptors and Uses Thereof.” The patent record provided identifies 1 patent associated with him.
Career Highlights
Van Dyk’s listed patent reflects work on engineered immune-cell receptors designed to recognize STEAP2. The record associates this work with AstraZeneca Pharmaceuticals LP.
Collaborations
The patent lists Gordon Moody and Chien-Ying Chang among Van Dyk’s collaborators.
Conclusion
Dewald Van Dyk’s documented patent activity centers on anti-STEAP2 chimeric antigen receptors and their potential uses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile